Risk Factors for Local Recurrence or Metastasis of Eyelid Sebaceous Gland Carcinoma After Wide Excision With Paraffin Section Control.
暂无分享,去创建一个
Y. Kitaguchi | S. Nakakura | H. Kakizaki | Yasuhiro Takahashi | Jacqueline Mupas-Uy | E. Takahashi | Emiko Takahashi | Y. Takahashi
[1] M. Zimmerman,et al. An Analysis of Conjunctival Map Biopsies in Sebaceous Carcinoma. , 2017, Ophthalmic plastic and reconstructive surgery.
[2] G. Czanner,et al. Perforin expression in eyelid sebaceous carcinomas: a useful and specific immunomarker for the differential diagnosis of eyelid carcinomas , 2016, Acta ophthalmologica.
[3] S. Kaliki,et al. Prognosis of eyelid sebaceous gland carcinoma based on the tumor (T) category of the American Joint Committee on Cancer (AJCC) classification , 2016, International Ophthalmology.
[4] S. Kaliki,et al. Neoadjuvant Systemic Chemotherapy in the Management of Extensive Eyelid Sebaceous Gland Carcinoma: A study of 10 Cases , 2016, Ophthalmic plastic and reconstructive surgery.
[5] C. Shields,et al. Sebaceous Carcinoma of the Ocular Region: The 2014 Professor Winifred Mao Lecture , 2015, Asia-Pacific journal of ophthalmology.
[6] S. Kaliki,et al. Sebaceous gland carcinoma of the eyelid: clinicopathological features and outcome in Asian Indians , 2015, Eye.
[7] V. White,et al. Sebaceous carcinoma: clinicopathologic features and diagnostic role of immunohistochemistry (including androgen receptor). , 2014, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[8] H. Choung,et al. Prognostic value of clinical and pathologic T stages defined by the American Joint Committee on Cancer for eyelid sebaceous carcinoma in Korea , 2014, Japanese Journal of Ophthalmology.
[9] T. Milman,et al. Diagnostic utility of adipophilin immunostain in periocular carcinomas. , 2014, Ophthalmology.
[10] H. Mudhar,et al. Excision and Delayed Reconstruction With Paraffin Section Histopathological Analysis for Periocular Sebaceous Carcinoma , 2014, Ophthalmic plastic and reconstructive surgery.
[11] F. Jakobiec,et al. Eyelid sebaceous carcinoma: clinicopathologic and multiparametric immunohistochemical analysis that includes adipophilin. , 2014, American journal of ophthalmology.
[12] Michelle T. Sun,et al. Sebaceous carcinoma in Japanese patients: clinical presentation, staging and outcomes , 2013, British Journal of Ophthalmology.
[13] V. White,et al. Periocular sebaceous gland carcinoma: A comprehensive review. , 2013, Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society.
[14] S. Walters,et al. Observational prospective cohort study of patients with newly-diagnosed ocular sebaceous carcinoma , 2012, British Journal of Ophthalmology.
[15] B. Esmaeli,et al. American Joint Committee on Cancer T category for eyelid sebaceous carcinoma correlates with nodal metastasis and survival. , 2012, Ophthalmology.
[16] E. Jones,et al. Periocular Cutaneous Malignancies: A Review of the Literature , 2012, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[17] G. Biswas,et al. Neoadjuvant chemotherapy in recurrent sebaceous carcinoma of eyelid with orbital invasion and regional lymphadenopathy. , 2010, Ophthalmic plastic and reconstructive surgery.
[18] H. Goto,et al. Sebaceous carcinoma of the eyelids: Thirty cases from Japan , 2008, Pathology international.
[19] Julia Song,et al. Sebaceous Cell Carcinoma of the Ocular Adnexa: Clinical Presentations, Histopathology, and Outcomes , 2008, Ophthalmic plastic and reconstructive surgery.
[20] A. Odashiro,et al. Histopathological review of sebaceous carcinoma of the eyelid , 2005, Journal of cutaneous pathology.
[21] C. Shields,et al. Sebaceous carcinoma of the ocular region: a review. , 2005, Survey of ophthalmology.
[22] C. Shields,et al. Sebaceous carcinoma of the eyelids: personal experience with 60 cases. , 2004, Ophthalmology.
[23] W. Lee,et al. Improved survival rates in sebaceous carcinoma of the eyelid , 2004, Eye.
[24] C. Shields,et al. Topical mitomycin-C for pagetoid invasion of the conjunctiva by eyelid sebaceous gland carcinoma. , 2002, Ophthalmology.
[25] C. Shields,et al. Outcome of patients with periocular sebaceous gland carcinoma with and without conjunctival intraepithelial invasion. , 2001, Ophthalmology.
[26] D. Tse,et al. Sebaceous Cell Carcinoma of the Eyelid and the Human Immunodeficiency Virus , 2000, Ophthalmic plastic and reconstructive surgery.
[27] W. Green,et al. Sebaceous gland carcinoma. Review of 40 cases. , 1984, Archives of ophthalmology.
[28] I. McLean,et al. Sebaceous carcinomas of the ocular adnexa: A clinicopathologic study of 104 cases, with five-year follow-up data. , 1982, Human pathology.
[29] H. D. Cavanagh,et al. Primary radiation therapy for meibomian gland carcinoma. , 1979, American journal of ophthalmology.
[30] N. Chou,et al. Meibomian Gland Carcinoma--A Clinicopathological Study of 156 Cases with Long-Period Follow-Up of 100 Cases , 1979 .
[31] E. Constant,et al. SEBACEOUS CELL CARCINOMA , 1968, Plastic and reconstructive surgery.
[32] M. Schulz,et al. Carcinoma of the eyelid; analysis of 301 cases and review of the literature. , 1949, The New England journal of medicine.
[33] A. O. Severance,et al. SEBACEOUS GLAND CARCINOMA , 1942, Annals of surgery.